Starling Oncology, Inc. STLN
6.70 USD -0.24 (-3.46%)
At closeNov 5, 2026, 4:36 PM EST
5.53 -1.17 -17.54%
After hours · Nov 5, 4:36 PM ET
6.64 Day range 7.02
2.32 52-week range 7.13
- YTD
- +88.20%
- 1 year
- +63.81%
- Market cap
- 682.84M
- EPS (ttm)
- -0.29
- YTD return
- +88.20%
- 1-year return
- +63.81%
- Volume
- 1.66M
- Avg volume
- 1.38M
- Open
- 6.88
- Previous close
- 6.94
- Day's range
- 6.64 – 7.02
- 52-week range
- 2.32 – 7.13
2Y +6.46 (+2307.14%)
Financials — quick view
STLN Revenue — quarterly 161.28M
STLN Net income — quarterly -8.24M
STLN EPS — quarterly -0.08
News
Starling Oncology Announces Third Quarter 2026 Earnings Release Date and Conference Call 
Needham Maintains Buy on Starling Oncology, Raises Price Target to $9 
Oncology Institute (NASDAQ:STLN) Shares Climb 6.1% – Should You Buy? 
Cedar Grove Capital Q3 2026 Portfolio Update 
Starling Oncology Leadership Highlights Recent and Upcoming Industry Conference Participation 
Starling Oncology: Improving Cash Flow And Gross Profit Fuel A Re-Rating 
12 Health Care Stocks Moving In Friday's After-Market Session 
Starling Oncology to Participate in Wells Fargo Healthcare Conference 
Starling Oncology Launches Starling Nexus™, a Technology Platform Built to Optimize Oncology Provider Engagement and Accelerate High-Quality Care at Scale 
Starling Oncology Q2 EPS $(0.08) Up From $(0.15) YoY, Sales $161.282M Up From $119.802M YoY
Your note
Sign in to keep a note on STLN — it syncs with the Stock Master app.